Ballentine Partners, LLC Zoetis Inc. Transaction History

Ballentine Partners, LLC

$5.81 Billion
Q3 2024

A detailed history of Ballentine Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 11,794 shares of ZTS stock, worth $2.09 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,794

Previous 11,796 0.02%

Holding current value

$2.09 Million

Previous $2.04 Million 12.72%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$172.58 - $196.48 $345 - $392	-2 Reduced 0.02%	11,794 $2.3 Million
Q2 2024 Aug 06, 2024	SELL	$145.54 - $178.83 $19,938 - $24,499	-137 Reduced 1.15%	11,796 $2.04 Million
Q1 2024 Apr 11, 2024	SELL	$165.67 - $199.94 $17,726 - $21,393	-107 Reduced 0.89%	11,933 $2.02 Million
Q4 2023 Jan 23, 2024	BUY	$151.44 - $200.09 $323,778 - $427,792	2,138 Added 21.59%	12,040 $2.38 Million
Q3 2023 Oct 19, 2023	BUY	$167.14 - $192.77 $23,566 - $27,180	141 Added 1.44%	9,902 $1.72 Million
Q2 2023 Jul 26, 2023	SELL	$160.94 - $186.23 $340,549 - $394,062	-2,116 Reduced 17.82%	9,761 $1.68 Million
Q1 2023 Apr 27, 2023	BUY	$145.48 - $175.02 $356,426 - $428,799	2,450 Added 25.99%	11,877 $1.98 Million
Q4 2022 Jan 27, 2023	BUY	$131.14 - $157.47 $24,392 - $29,289	186 Added 2.01%	9,427 $0
Q3 2022 Oct 26, 2022	BUY	$148.29 - $182.55 $99,947 - $123,038	674 Added 7.87%	9,241 $1.37 Million
Q2 2022 Aug 09, 2022	BUY	$155.97 - $200.09 $1,871 - $2,401	12 Added 0.14%	8,567 $1.47 Million
Q1 2022 May 05, 2022	BUY	$181.39 - $234.03 $3,990 - $5,148	22 Added 0.26%	8,555 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$193.69 - $247.03 $71,084 - $90,660	367 Added 4.49%	8,533 $2.08 Million
Q3 2021 Oct 27, 2021	BUY	$189.29 - $209.69 $4,732 - $5,242	25 Added 0.31%	8,166 $1.59 Million
Q2 2021 Aug 12, 2021	BUY	$155.9 - $187.99 $207,035 - $249,650	1,328 Added 19.49%	8,141 $1.52 Million
Q1 2021 May 11, 2021	SELL	$144.0 - $169.39 $28,656 - $33,708	-199 Reduced 2.84%	6,813 $1.07 Million
Q4 2020 Jan 25, 2021	SELL	$157.07 - $174.35 $42,723 - $47,423	-272 Reduced 3.73%	7,012 $1.16 Million
Q3 2020 Oct 22, 2020	SELL	$137.1 - $165.37 $312,313 - $376,712	-2,278 Reduced 23.82%	7,284 $1.21 Million
Q2 2020 Jul 31, 2020	BUY	$111.92 - $142.53 $738,000 - $939,842	6,594 Added 222.17%	9,562 $1.31 Million
Q1 2020 Apr 23, 2020	BUY	$92.66 - $144.94 $23,165 - $36,235	250 Added 9.2%	2,968 $350,000
Q4 2019 Jan 22, 2020	BUY	$116.25 - $133.25 $5,115 - $5,863	44 Added 1.65%	2,718 $360,000
Q3 2019 Oct 21, 2019	SELL	$112.57 - $128.43 $9,118 - $10,402	-81 Reduced 2.94%	2,674 $333,000
Q2 2019 Jul 25, 2019	BUY	$97.98 - $114.28 $269,934 - $314,841	2,755 New	2,755 $312,000
Q4 2018 Feb 04, 2019	SELL	$79.28 - $95.27 $175,446 - $210,832	-2,213 Closed	0 $0
Q3 2018 Oct 30, 2018	BUY	$83.5 - $93.23 $184,785 - $206,317	2,213 New	2,213 $203,000

Others Institutions Holding ZTS

# of Institutions

1,956

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Account

Ballentine Partners, LLC Zoetis Inc. Transaction History